Journal Mobile Options
Table of Contents
Vol. 26, No. 2, 2008
Issue release date: April 2008
Dig Dis 2008;26:140–148
(DOI:10.1159/000116772)

Affective and Psychiatric Disorders in Celiac Disease

Addolorato G. · Leggio L. · D’Angelo C. · Mirijello A. · Ferrulli A. · Cardone S. · Vonghia L. · Abenavoli L. · Leso V. · Nesci A. · Piano S. · Capristo E. · Gasbarrini G.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Several extraintestinal clinical manifestations have been reported in celiac disease (CD). Among them, growing evidence suggests the association between CD and affective and psychiatric disorders. In this review the most frequent affective and psychiatric disorders associated with CD and the possible mechanisms involved in these associations were analyzed. The available data suggest that screening for CD in patients with affective and/or psychiatric symptoms may be useful since these disorders could be the expression of an organic disease rather than primary psychiatric illnesses.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Corazza GR, Gasbarrini G: Coeliac disease in adults. Baillieres Clin Gastroenterol 1995;9:329–350.
  2. Sollid LM: Coeliac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol 2002;2:647–655.
  3. Farrell RJ, Kelly CP: Celiac sprue. N Engl J Med 2002;346:180–188.
  4. Capristo E, Addolorato G, Mingrone G, De Gaetano A, Greco AV, Tataranni PA, Gasbarrini G: Change in body composition, substrate oxidation, and resting metabolic rate in adult celiac disease patients after 1-year gluten-free diet treatment. Am J Clin Nutr 2000;72:76–81.
  5. Hernandez L, Green PH: Extraintestinal manifestations of celiac disease. Curr Gastroenterol Rep 2006;8:383–389.
  6. Hallert C, Derefeldt T: Psychic disturbances in adult celiac disease. I. Clinical observations. Scand J Gastroenterol 1982;17:17– 19.
  7. Hallert C, Aström J: Psychic disturbances in adult coeliac disease. II. Psycological findings. Scand J Gastroenterol 1982;17:21–24.
  8. Hallert C, Astrom J, Walan A: Reversal of psychopathology in adult coeliac disease with the aid of pyridoxine (vitamin B6). Scand J Gastroenterol 1983;18:299–304.
  9. Hernanz A, Polanco I: Plasma precursor amino acids of central nervous system monoamines in children with coeliac disease. Gut 1991;32:1478–1481.
  10. Addolorato G, Stefanini GF, Capristo E, Caputo F, Gasbarrini A, Gasbarrini G: Anxiety and depression in adult untreated celiac subjects and in patients affected by inflammatory bowel disease: a personality ‘trait’ or a reactive illness? Hepatogastroenterology 1996;43:1513–1517.
  11. Ciacci C, Iavarone A, Mazzacca G, De Rosa A: Depressive symptoms in adult coeliac disease. Scand J Gastroenterol 1998;33:247–250.
  12. Ciacci C, D’Agate C, De Rosa A, Franzese C, Errichiello S, Gasperi V, Pardi A, Quagliata D, Visentini S, Greco L: Self-rated quality of life in celiac disease. Dig Dis Sci 2003;48:2216–2220.
  13. Corvaglia L, Catamo R, Pepe G, Lazzari R, Corvaglia E: Depression in adult untreated celiac subjects: diagnosis by the pediatrician. Am J Gastroenterol 1999;94:839–843.
  14. Addolorato G, Capristo E, Ghittoni G, Valeri C, Mascianà R, Ancona C, Gasbarrini G: Anxiety but not depression decreases in coeliac patients after one-year gluten-free diet: a longitudinal study. Scand J Gastroenterol 2001;5:502–506.

    External Resources

  15. Wells KB, Golding MJ, Burnam MA: Psychiatric disorder in a sample of the general population with and without chronic medical conditions. Am J Psychiatry 1998;8:976–981.
  16. Pynnönen P, Isometsa E, Aalberg V, Verkasalo M, Savilahti E: Is coeliac disease prevalent among adolescent psychiatric patients? Acta Paediatr 2002;91:657–659.
  17. Fera T, Cascio B, Angelini G, Martini S, Guidetti CS: Affective disorders and quality of life in adult coeliac disease patients on a gluten-free diet. Eur J Gastroenterol Hepatol 2003;15:1287–1292.
  18. Siniscalchi M, Iovino P, Tortora R, Forestiero S, Somma A, Capuano L, Franzese MD, Sabbatini F, Ciacci C: Fatigue in adult coeliac disease. Aliment Pharmacol Ther 2005;22:489–494.
  19. Ciacci C, Iavarone A, Siniscalchi M, Romano R, De Rosa A: Psychological dimension of celiac disease: toward an integrated approach. Dig Dis Sci 2002;9:2082–2087.

    External Resources

  20. De Rosa A, Troncone A, Vacca M, Ciacci C: Characteristics and quality of illness behavior in celiac disease. Psychosomatics 2004;45:336–342.
  21. Addolorato G, Mirijello A, D’Angelo C, Leggio L, Ferrulli A, Vonghia L, Cardone S, Leso V, Miceli A, Gasbarrini G: Social phobia in celiac disease. Scand J Gastroenterol 2008; DOI: 10.1080/00365520701768802.
  22. Farthing MJG, Edwards CRW, Rees LH, Dawson AM: Male gonadal function in coeliac disease: sexual dysfunction, infertility and semen quality. Gut 1982;23:608–614.
  23. Farthing MJG, Rees LH, Edwards CRW, Dawson AM: Male gonadal function in coeliac disease. 2. Sex hormones. Gut 1983;24:127–135.
  24. Ciacci C, De Rosa A, de Michele G, Savino G, Squillante A, Iovino P, Sabbatini F, Mazzacca G: Sexual behaviour in untreated and treated coeliac patient. Eur J Gastroenterol Hepatol 1998;10:649–651.
  25. Hallert C, Astrom J, Sedvall G: Psychological disturbances in adult coeliac disease. III. Reduced central monoamine metabolism and sign of depression. Scand J Gastroenterol 1982;17:21–24.
  26. Smith K, Fairburn C, Cowen P: Relapse of depression after rapid depletion of tryptophan. Lancet 1997;349:915–919.
  27. Sourkes TL: Nutrients and the cofactors required for monoamine synthesis in nervous tissue; in Wurtman RJ, Wurtman JJ (eds): Nutrition and the Brain. New York, Raven Press, 1979, vol 3, pp 265–299.
  28. Wildmann J, Vetter W, Ranalder UB, Schmidt K, Maurer R, Mohler H: Occurrence of pharmacologically active benzodiazepines in trace amounts in wheat and potato. Biochem Pharmacol 1988;37:3549– 3559.
  29. Medina JH, Pena C, Levi de Stein M, Wolfman C, Paladini AC: Benzodiazepine-like molecules, as well as other ligands for the brain benzodiazepine receptors, are relatively common constituents of plants. Biochem Biophys Res Commun 1989;165:547–553.
  30. Addolorato G, Capristo E, Stefanini GF, Gasbarrini G: Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status. Scand J Gastroenterol 1997;32:1013–1021.
  31. Addolorato G, Di Giuda D, De Rossi G, Valenza V, Domenicali M, Caputo F, Gasbarrini A, Capristo E, Gasbarrini G: Regional hypoperfusion in patients with celiac disease. Am J Med 2004;116:312–316.
  32. Usai P, Serra A, Marini B, Mariotti S, Satta L, Boi MF, Spanu A, Loi G, Piga M: Frontal cortical perfusion abnormalities related to gluten intake and associated autoimmune disease in adult coeliac disease: 99mTc-ECD brain SPECT study. Dig Liver Dis 2004;36:513–518.
  33. Grasby PM, Bench C: Neuroimaging in mood disorders. Curr Opin Psychiatry 1997;10:73–78.

    External Resources

  34. Davidson RJ, Abercrombie H, Nitschke JB, Putnam K: Regional brain function, emotion and disorders of emotion. Curr Opin Neurobiol 1999;9:228–234.
  35. Hallert C, Granno C, Grant C, Hulten S, Midhagen G, Strom M, Svensson H, Valdimarsson T, Wickestrom T: Quality of life of adult coeliac patients treated for 10 years. Scand J Gastroenterol 1998;33:933–938.
  36. Hallert C, Sandlund O, Broqvist M: Perceptions of health-related quality of life men and women living with coeliac disease. Scand J Caring Sci 2003;17:301–307.
  37. Usai P, Minerba L, Marini B, Cossu R, Spada S, Carpiniello B, Cuomo R, Boy MF: Case-control study on health-related quality of life in adult coeliac disease. Dig Liver Dis 2002;34:547–552.
  38. Lee A, Newman JM: Celiac diet: its impact on quality of life. J Am Diet Assoc 2003;103:1533–1535.
  39. Hauser W, Gold J, Stein J, Caspary WF, Stallmach A: Health-related quality of life in adult coeliac disease in Germany: results of a national survey. Eur J Gastroenterol Hepatol 2006;18:747–754.
  40. Zarkadas M, Cranney A, Case S, Molloy M, Switzer C, Graham ID, Butzner JD, Rashid M, Warren RE, Burrows V: The impact of a gluten-free diet on adults with coeliac disease: results of a national survey. J Hum Nutr Diet 2006;19:41–49.
  41. O’Leary C, Wieneke P, Healy M,Cronin C, O’ Regan P, Shanahan F: Celiac disease and the transition from childhood to adulthood: a 28-year follow-up. Am J Gastroenterol 2004;99:2437–2441.
  42. Addolorato G, De Lorenzi G, Abenavoli L, Leggio L, Capristo E, Gasbarrini G: Psychological support counselling improves gluten-free diet compliance in coeliac patients with affective disorders. Aliment Pharmacol Ther 2004;20:777–782.
  43. Leggio L, Abenavoli L, Gasbarrini G, Addolorato G: Psychological support counselling: a new strategy to increase gluten-free diet compliance in celiac patients. Am J Gastroenterol 2005;100:1424–1425.
  44. Kalaydjian AE, Eaton W, Cascella N, Fasano A: The gluten connection: the association between schizophrenia and celiac disease. Acta Psychiatr Scand 2006;113:82–90.
  45. Bender L: Childhood schizophrenia. Psychiatr Q 1953;27:663–681.
  46. Dohan FC: Wartime changes in hospital admissions for schizophrenia. A comparison of admission for schizophrenia and other psychoses in six countries during World War II. Acta Psychiatr Scand 1966;42:1–23.
  47. Dohan FC: Wheat ‘consumption’ and hospital admissions for schizophrenia during World War II. A preliminary report. Am J Clin Nutr 1966;18:7–10.
  48. Dohan FC, Grasberger JC, Lowell FM, Johnston HT Jr, Arbegast AW: Relapsed schizophrenics: more rapid improvement on a milk- and cereal-free diet. Br J Psychiatry 1969;115:595–596.
  49. Dohan FC, Grasberger JC: Relapsed schizophrenics: earlier discharge from the hospital after cereal-free, milk-free diet. Am J Psychiatry 1973;130:685–688.
  50. Singh MM, Kay SR: Study of gluten effect in schizophrenia. Arch Gen Psychiatry 1983;40:345–346.
  51. Rice JR, Ham CH, Gore WE: Another look at gluten in schizophrenia. Am J Psychiatry 1978;135:1417–1418.
  52. Vlissides DN, Venulet A, Jenner FA: A double-blind gluten-free/gluten-load controlled trial in a secure ward population. Br J Psychiatry 1986;148:447–452.
  53. Potkin SG, Weinberger D, Kleinman J, Nasrallah H, Luchins D, Bigelow L, Linnoila M, Fischer SH, Bjornsson TD, Carman J, Gillin JC, Wyatt RJ: Wheat gluten challenge in schizophrenic patients. Am J Psychiatry 1981;138:1208–1211.
  54. Storms LH, Clopton JM, Wright C: Effects of gluten on schizophrenics. Arch Gen Psychiatry 1982;39:323–327.
  55. Osborne M, Crayton JW, Javaid J, Davis JM: Lack of effect of a gluten-free diet on neuroleptic blood levels in schizophrenic patients. Biol Psychiatry 1982;17:627–629.
  56. De Santis A, Addolorato G, Romito A, Caputo S, Giordano A, Gambassi G, Taranto C, Manna R, Gasbarrini G: Schizophrenic symptoms and SPECT abnormalities in a coeliac patient: regression after a gluten-free diet. J Intern Med 1997;242:421–423.
  57. Desplat-Jego S, Bernard D, Bagneres D: Neuropsychiatric symptoms in the elderly: let us not forget celiac disease. J Am Geriatr Soc 2003;51:884–885.
  58. Eaton W, Mortensen PB, Agerbo E, Byrne M, Mors O, Ewald H: Coeliac disease and schizophrenia: population based case-control study with linkage of Danish national registers. BMJ 2004;328:438–439.
  59. Peleg R, Ben-Zion ZI, Peleg A, Gheber L, Kotler M, Weizman Z, Shiber A, Fich A, Horowitz Y, Shvartzman P: ‘Bread madness’ revised: screening for specific celiac antibodies among schizophrenia patients. Eur Psychiatry 2004;19:311–314.
  60. West J, Logan RF, Hubbard RB, Card TR: Risk of schizophrenia in people with coeliac disease, ulcerative colitis and Crohn’s disease: a general population-based study. Aliment Pharmacol Ther 2006;23:71–74.
  61. Wei J, Hemmings GP: Gene, gut and schizophrenia: the meeting point for the gene-environment interaction in developing schizophrenia. Med Hypotheses 2005;64:547–552.
  62. Carta MG, Hardoy MC, Boi MF, Mariotti S, Carpiniello B, Usai P: Association between panic disorder, major depressive disorder and celiac disease: a possible role of thyroid autoimmunity. J Psychosom Res 2002;53:789–793.
  63. Carta MG, Hardoy MC, Usai P, Carpiniello B, Angst J: Recurrent brief depression in celiac disease. J Psychosom Res 2003;55:573–574.
  64. Pynnönen PA, Isometsa ET, Aaronen ET, Verkasalo MA, Savilahti E, Aalberg VA: Mental disorders in adolescents with celiac disease. Psychosomatics 2004;45:325–335.
  65. Goodwin MS, Goodwin TC: In a dark mirror. Ment Hyg 1969;53:550–563.
  66. Goodwin MS, Cowen MA, Goodwin TC: Malabsorption and cerebral dysfunction: a multivariate and comparative study of autistic children. J Autism Child Schizophr 1971;1:48–62.
  67. Sullivan R: Hunches on some biological factors in autism. J Autism Child Schizophr 1975;5:177–184.
  68. Reichelt KL, Saelid G, Lindback T, Boler JB: Childhood autism: a complex disorder. Biol Psychiatry 1986;21:1279–1290.
  69. Serratrice J, Dusdier P, Kaladjian A, Granel B, Azorin JM, Laugier R, Berenguer M, Weiller PJ: Psychosis revealing a silent celiac disease in a young women with trisomy 21. Presse Méd 2002;31:1551–1553.
  70. Pavone L, Fiumara A, Bottaro G, Mazzone D, Coleman M: Autism and celiac disease: failure to validate the hypothesis that a link might exist. Biol Psychiatry 1997;42:72–75.
  71. Pellegrino M, D’Altilia MR, Germano M: Untreated coeliac disease and attempted suicide. Lancet 1995;346:915.
  72. Ferrara A, Fontana VJ: Celiac disease and anorexia nervosa. NY State J Med 1966;66:100–105.
  73. Ricca V, Mannucci E, Calabrò A, Di Bernardo M, Cabras PL, Rotella CM: Anorexia nervosa and celiac disease: case report. Int J Eat Disord 2000;27:119–122.
  74. Jost PJ, Stengel SM, Huber W, Sarbia M, Peschel C, Duyster J: Very severe iron-deficiency anemia in a patient with celiac disease and bulimia nervosa: a case report. Int J Hematol 2005;82:310–311.
  75. Eberman LE, Cleary MA: Celiac disease in an elite female collegiate volleyball athlete: a case report. J Athl Train 2005;40:360–364.
  76. Yucel B, Ozbey N, Demir K, Polat A, Yager J: Eating disorders and celiac disease: a case report. Int J Eat Disord 2006;39:530–532.
  77. Huebner FR, Lieberman KW, Rubino RP, Wall JS: Demonstration of high opioid-like activity in isolated peptides from wheat gluten hydrolysates. Peptides 1984;5:1139–1147.
  78. Blass EM, Fitzgerald E: Milk-induced analgesia and comforting in 10-day-old rats: opioid mediation. Pharmacol Biochem Behav 1988;29:9–13.
  79. Wada J, Gibson WC: Behavioral and EEG changes induced by injection of schizophrenic urine extract. Arch Neurol Psychiatry 1959;81:747–764.
  80. Drysdale A, Deacon R, Lewis P, Olley J, Electricwala A, Sherwood R: A peptide-containing fraction of plasma from schizophrenic patients which binds to opiate receptors and induces hyperreactivity in rats. Neuroscience 1982;7:1567–1573.
  81. Dohan FC, Harper EH, Clark MH, Rodrigue RB, Zigas V: Is schizophrenia rare if grain is rare? Biol Psychiatry 1984;19:385–399.
  82. Wood NC, Hamilton I, Axon AT, Khan SA, Quirke P, Mindham RH, McGuigan K, Prison HM: Abnormal intestinal permeability. An aetiological factor in chronic psychiatric disorders? Br J Psychiatry 1987;150:853–856.
  83. Montalto M, Cuoco L, Ricci R, Maggiano N, Vecchio FM, Gasbarrini G: Immunohistochemical analysis of ZO-1 in the duodenal mucosa of patients with untreated and treated celiac disease. Digestion 2002;65:227–233.
  84. Naluai AT, Nilsson S, Gudjonsdottir AH, Louka AS, Ascher H, Ek J, Hallberg B, Samuelsson L, Kristiansson B, Martinsson T, Nerman O, Sollid LM, Wahlstrom J: Genome-wide linkage analysis of Scandinavian affected sib-pairs supports presence of susceptibility loci for celiac disease on chromosomes 5 and 11. Eur J Hum Genet 2001;9:938–944.
  85. Greco L, Babron MC, Corazza GR, Percopo S, Sica R, Clot F, Fulchignoni-Lataud MC, Zavattari P, Momigliano-Richiardi P, Casari G, Gasparini P, Tosi R, Mantovani V, De Virgiliis S, Iacono G, D’Alfonso A, Selinger-Leneman H, Lemainque A, Serre JL, Clerget-Darpoux F: Existence of a genetic risk factor on chromosome 5q in Italian coeliac disease families. Ann Hum Genet 2001;65:35–41.
  86. Holopainen P, Mustalahti K, Uimari P, Collin P, Maki M, Partanen J: Candidate gene regions and genetic heterogeneity in gluten sensitivity. Gut 2001;48:696–701.
  87. Mascord I, Freed D, Durrant B: Antibodies to foodstuffs in schizophrenia. Br Med J 1978;1:1351.
  88. Dohan FC, Martin L, Grasberger JC, Boehme D, Cottrell JC: Antibodies to wheat gliadin in blood of psychiatric patients: possible role of emotional factors. Biol Psychiatry 1972;5:127–137.
  89. Kinnel HG, Kirkwood E, Lewis C: Food antibodies in schizophrenia. Psychol Med 1982;12:85–89.
  90. Ashkenazi A, Krasilowsky D, Levin S, Idar D, Kalian M, Or A, Ginat Y, Halperin B: Immunologic reaction of psychotic patients to fraction of gluten. Am J Psychiatry 1979;136:1306–1309.
  91. Kuruoglu AC, Kapucu O, Atasever T, Arikan Z, Isik E, Unlu M: Technetium-99m- HMPAO brain SPECT in anorexia nervosa. J Nucl Med 1998;39:304–306.
  92. Addolorato G, Taranto C, Capristo E, Gasbarrini G: A case of marked cerebellar atrophy in a woman with anorexia nervosa and cerebral atrophy and a review of the literature. Int Eat Disord 1998;24:443–447.
  93. Delvenne V, Lostra F, Goldman S Delvenne V, Goldman S, De Maertelaer V, Simon Y, Luxen A, Lotstra F: Brain hypometabolism of glucose in anorexia nervosa: normalization after weight gain. Biol Psychiatry 1996;40:761–768.
  94. Rush PJ, Inman R, Bernstein M, Carlen P, Resh L: Isolated vasculitis of the central nervous system in a patient with coeliac disease. Am J Med 1986;81:1092–1094.
  95. Knight JG: Dopamine-receptor stimulating antibodies: a possible cause of schizophrenia. Lancet 1982;2:1073–1076.
  96. Ivanyi P, Droes J, Schreuder GMT, D’Amaro J, Van Rood JJ: A search for association of HLA antigen with paranoid schizophrenia. Tissue Antigen 1983;22:93–95.
  97. Miyanaga K, Machiyama Y, Juji T: Schizophrenic disorders and HLA DR antigen. Biol Psychiatry 1984;19:121–129.
  98. Hadjivassiliou M, Gibson A, Davies-Jones GA, Lobo AJ, Stephenson TJ, Milford-Ward A: Does cryptic gluten sensitivity play a part in neurological illness? Lancet 1996;347:369–371.
  99. Volta U, De Giorgio R, Petrolini N, Stangbellini V, Barbara G, Granito A, De Ponti F, Corinaldesi R, Bianchi FB: Clinical findings and anti-neuronal antibodies in coeliac disease with neurological disorders. Scand J Gastroenterol 2002;37:1276–1281.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50